{
    "Trade/Device Name(s)": [
        "iHealth Align Gluco-Monitoring System",
        "iHealth BG5L wireless Smart Gluco-Monitoring System",
        "iHealth BG5 wireless Smart Gluco-Monitoring System"
    ],
    "Submitter Information": "Andon Health Co., Ltd.",
    "510(k) Number": "K150833",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133790"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JQP"
    ],
    "Summary Letter Date": "November 2, 2015",
    "Summary Letter Received Date": "November 4, 2015",
    "Submission Date": "March 20, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.2100"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Blood Glucose Monitoring System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood (fingertip, palm, forearm, upper arm, calf, thigh)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "iHealth Align Glucose meter (BG1)",
        "iHealth BG5 wireless Smart meter",
        "iHealth BG5L wireless Smart meter",
        "iHealth Gluco-Smart App (iOS application)"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-based glucose measurement (glucose oxidase)"
    ],
    "Methodologies": [
        "In vitro quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Reagent",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for iHealth Align, BG5, and BG5L Smart Gluco-Monitoring Systems for quantitative measurement of glucose in capillary whole blood using enzyme-based meters and iOS application",
    "Indications for Use Summary": "Intended for self-testing by individuals with diabetes at home to monitor the effectiveness of diabetes control by quantitatively measuring glucose in fresh capillary whole blood from multiple sites; not for diagnosis or screening of diabetes or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}